Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (1): 139-149.doi: 10.13481/j.1671-587X.20230118
• Research in clinical medicine • Previous Articles Next Articles
Wuyue TANG1,2,Shuojie LI1,2,Lijuan PANG1,2,3(
)
Received:2022-01-03
Online:2023-01-28
Published:2023-02-03
Contact:
Lijuan PANG
E-mail:ocean123456@shzu.edu.cn
CLC Number:
Wuyue TANG,Shuojie LI,Lijuan PANG. Bioinformatics analysis of splicing factor-alternative splicing regulatory network based on alternative splicing data in lung adenocarcinoma tissue[J].Journal of Jilin University(Medicine Edition), 2023, 49(1): 139-149.
Tab.1
Univariate Cox regression analysis of prognostic factors in LUAD patients"
| Item | P value | Hazard ratio |
|---|---|---|
| Age | 0.883 | 0.999(0.979-1.019) |
| Gender | 0.977 | 1.006(0.688-1.471) |
| TNM stage | <0.001 | 1.655(1.393-1.966) |
| T stage | <0.001 | 1.594(1.270-2.001) |
| M stage | 0.077 | 1.762(0.941-3.298) |
| N stage | <0.001 | 1.803(1.457-2.231) |
| AA-risk score | 0.021 | 1.402(1.044-1.982) |
| AD-risk score | 0.003 | 1.671(1.245-2.390) |
| AP-risk score | 0.008 | 0.608(0.459-0.895) |
| AT-risk score | 0.002 | 1.667(1.241-2.288) |
| ES-risk score | 0.006 | 1.486(1.092-2.176) |
| ME-risk score | <0.001 | 1.677(1.243-2.339) |
| RI-risk score | 0.026 | 1.367(0.997-1.871) |
| 1 | ZHANG G H, DONG R, KONG D M, et al. The effect of GLUT1 on the survival rate and immune cell infiltration of lung adenocarcinoma and squamous cell carcinoma: a meta and bioinformatics analysis[J]. Anticancer Agents Med Chem, 2022, 22(2): 223-238. |
| 2 | JIA K R, WU Y C, HUANG J, et al. Survival-associated alternative splicing events in pan-renal cell carcinoma[J]. Front Oncol, 2019, 9: 1317. |
| 3 | WAN Q, SANG X, JIN L, et al. Alternative splicing events as indicators for the prognosis of uveal melanoma[J]. Genes (Basel), 2020, 11(2): E227. |
| 4 | CHEN H Q, CARROT-ZHANG J, ZHAO Y, et al. Genomic and immune profiling of pre-invasive lung adenocarcinoma[J]. Nat Commun, 2019, 10(1): 5472. |
| 5 | RAVEH E, MATOUK I J, GILON M, et al. The H19 long non-coding RNA in cancer initiation, progression and metastasis—a proposed unifying theory[J]. Mol Cancer, 2015, 14: 184. |
| 6 | ZHANG Y J, YAO X Y, ZHOU H, et al. OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers[J]. Nucleic Acids Res, 2022, 50(D1): D1340-D1347. |
| 7 | SONG Q L, YI F T, ZHANG Y H, et al. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell[J]. BMC Cancer, 2019, 19(1): 499. |
| 8 | LIN C W, YU B W, ZHANG M, et al. Systematic analyses of the differentially expressed alternative splicing events in gastric cancer and its clinical significance[J]. Front Genet, 2020, 11: 522831. |
| 9 | COOMER A O, BLACK F, GREYSTOKE A, et al. Alternative splicing in lung cancer[J]. Biochim Biophys Acta Gene Regul Mech, 2019, 1862(11/12): 194388. |
| 10 | DE FRAIPONT F, GAZZERI S, CHO W C, et al. Circular RNAs and RNA splice variants as biomarkers for prognosis and therapeutic response in the liquid biopsies of lung cancer patients[J]. Front Genet, 2019, 10: 390. |
| 11 | WAN L D, YU W Y, SHEN E H, et al. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer[J]. Gut, 2019, 68(1): 118-129. |
| 12 | URBANSKI L M, LECLAIR N, ANCZUKÓW O. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics[J]. Wiley Interdiscip Rev RNA, 2018, 9(4): e1476. |
| 13 | CERASUOLO A, BUONAGURO L, BUONAGURO F M, et al. The role of RNA splicing factors in cancer: regulation of viral and human gene expression in human papillomavirus-related cervical cancer[J]. Front Cell Dev Biol, 2020, 8: 474. |
| 14 | SOUBISE B, JIANG Y, DOUET-GUILBERT N,et al. RBM22, a key player of pre-mRNA splicing and gene expression regulation, is altered in cancer[J]. Cancers (Basel), 2022, 14(3): 643. |
| 15 | HUANG X Y, SHI H Y, SHI X H, et al. LncRNA FBXL19-AS1 promotes proliferation and metastasis of cervical cancer through upregulating COL1A1 as a sponge of miR-193a-5p[J]. J Biol Res (Thessalon), 2021, 28(1): 20. |
| 16 | MELNYK J E, STERI V, NGUYEN H G, et al. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells[J]. Bioorg Med Chem, 2020, 28(20): 115712. |
| 17 | WOJTUSZKIEWICZ A, ASSARAF Y G, MAAS M J,et al. Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance[J]. Expert Opin Drug Metab Toxicol, 2015, 11(5): 673-689. |
| 18 | LIM B, KIM C, KIM J H, et al. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites[J].Oncotarget,2016,7(7):8055-8066. |
| 19 | SONG H, WANG Y P, SHI C J, et al. SH3KBP1 promotes glioblastoma tumorigenesis by activating EGFR signaling[J]. Front Oncol, 2020, 10: 583984. |
| 20 | SHI Y X, ZHU T, ZOU T, et al. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma[J]. Oncotarget, 2016, 7(51): 85235-85243. |
| 21 | LI J F, HE X, WU X T, et al. miR-139-5p inhibits lung adenocarcinoma cell proliferation, migration, and invasion by targeting MAD2L1[J]. Comput Math Methods Med, 2020, 2020: 2953598. |
| 22 | ZHANG J F, ZHANG J, XU S P, et al. Hypoxia-induced TPM2 methylation is associated with chemoresistance and poor prognosis in breast cancer[J]. Cell Physiol Biochem, 2018, 45(2): 692-705. |
| 23 | LIU S W, ZENG F P, FAN G W, et al. Identification of hub genes and construction of a transcriptional regulatory network associated with tumor recurrence in colorectal cancer by weighted gene co-expression network analysis[J]. Front Genet, 2021, 12: 649752. |
| 24 | VARISLI L. Identification of new genes downregulated in prostate cancer and investigation of their effects on prognosis[J].Genet Test Mol Biomarkers,2013,17(7): 562-566. |
| 25 | LIU Q, FANG L M, WU C J. Alternative splicing and isoforms: from mechanisms to diseases[J]. Genes, 2022, 13(3): 401. |
| 26 | PÉREZ-CALERO C, BAYONA-FELIU A, XUE X Y, et al. UAP56/DDX39B is a major cotranscriptional RNA-DNA helicase that unwinds harmful R loops genome-wide[J].Genes Dev,2020,34(13/14): 898-912. |
| 27 | AWASTHI S, CHAKRAPANI B, MAHESH A,et al. DDX39B promotes translation through regulation of pre-ribosomal RNA levels[J]. RNA Biol, 2018, 15(9): 1157-1166. |
| 28 | ZHANG H N, HE C C, GUO X X, et al. DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1[J]. Cell Death Discov, 2022, 8(1): 30. |
| 29 | XU Z Z, LI X M, LI H X, et al. Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA[J].Oncogene,2020,39(47):7051-7062. |
| 30 | WEI J H, LU J, CAO Y, et al. DDX39B predicts poor survival and associated with clinical benefit of anti-PD-L1 therapy in ccRCC[J]. Curr Cancer Drug Targets, 2021, 21(10): 849-859. |
| 31 | ISHIMI Y. Regulation of MCM2-7 function[J]. Genes Genet Syst, 2018, 93(4): 125-133. |
| 32 | WANG J Z, ZHU W, HAN J, et al. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer[J]. Cancer Commun (Lond), 2021, 41(7): 560-575. |
| [1] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [2] | Xiaohui LIANG,Wenna LIU,Jianbo ZHAO. Bioinformatic analysis on PAQR3 expression in hepatocellular carcinoma and its correlations with T lymphocyte infiltration, immune checkpoint genes, and patient survival [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 781-790. |
| [3] | Limei WEN,Yali GUO,Wenmei MA,Taotao XUE,Ruoyu GENG,Chong MA,Xinhong ZHANG,Jianhua YANG. Bioinformatic analysis of TCGA database based on INPP4B gene expression in hepatocellular carcinoma and its experimental validation [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1618-1629. |
| [4] | Han XUE,Yuxin FAN,Ting ZHANG,Zhimin LI,Mingge HUO,Xingang GUAN. Preparation of nanodrug PTX2 NPs and its killing effect on human lung cancer A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1260-1266. |
| [5] | Yu LIANG,Jinyu YU,Zhonggao XU,Wanning WANG. Expression characteristics of FOSB in kidney tissue from IgA nephropathy and other common kidney diseases [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1281-1292. |
| [6] | Fan WANG,Xin WEN,Yixuan WANG,Yuan WANG. Effect of gap junction β2 on prognosis of patients with lung adenocarcinoma and biological behavior of lung adenocarcinoma A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 716-726. |
| [7] | Wenchang CAI,Yuqi LIU,Han WANG,Helin WANG,Zhenjiang WANG,Zishen XIAO,Shiyuan MA,Liping AN,Yanbo LIU. Expression of protein kinase D2 in bladder cancer tissue and its effect on tumor immune microenvironment [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 378-391. |
| [8] | Yuting LIU,Ying YU,Guizhen LI,Qinxue SHI,Binbin LI. Bioinformatics analysis based on expression of splicing factor SRSF9 in head and neck squamous cell carcinoma and clinical significance [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 379-391. |
| [9] | Hui YE,Zhe SUN,Liting ZHOU,Wen QI,Lin YE. Bioinformatics analysis on differentially expressed genes in lung adenocarcinoma based on GEO and TCGA Databases [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1491-1503. |
| [10] | Yiming ZHAO,Haiyang XU. Bioinformatics analysis on related genes and candidate pathways of glioblastoma multiforme [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1280-1289. |
| [11] | Xiaoying ZHAO,Jiansheng SU,Jiahui MA,Yuefeng WANG,Dan WANG,Liyuan SUN. Bioinformatics analysis based on activity of heterotrimeric peptide H5LL and construction of recombinant Lactic acid bacteria expression vector [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1366-1374. |
| [12] | Chang GAO,Yan LIU,Haoxiang YANG,Cuicui ZHANG. Effect of long non-coding RNA MALAT1 on angiogenesis of human brain microvascular endothelial cells induced by oxygen-glucose deprivation/reoxygenation hypoxic [J]. Journal of Jilin University(Medicine Edition), 2023, 49(4): 832-839. |
| [13] | Lingyao XU,Shutang WEI,Yong DONG,Zhenglu SUN,Junbo ZHAO,Dazheng HAN. Regulatory effect of lncRNA MALAT1 on activation of hepatic stellate cell and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 697-705. |
| [14] | Junjie HOU,Xuguang MI,Xiaonan LI,Xiaonan LI,Ying YANG,Xiaodan LU,Yanqiu FANG,Ningyi JIN. Establishment and evaluation of prognostic model of lung adenocarcinoma based on lactate metabolism gene [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1546-1554. |
| [15] | Liantao HU,Wenjun DENG,Shizhen LU,Luo SUN,Xuebing LI,Chuhao LI,Xinran WANG,chunbing ZHANG,Yue LI,Weiqun WANG. Bioinformatics analysis on CC chemokine ligand 20 expression in hepatocellular carcinoma tissue and its effect on prognostic assessment of liver hepatocellular carcinoma [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 1010-1017. |
|